Genome-wide RNAi screen identifies the Parkinson disease GWAS risk locus<i>SREBF1</i>as a regulator of mitophagy

Rachael M. Ivatt(Medical Research Council), Álvaro Sánchez-Martínez(Medical Research Council), Vinay K. Godena(Medical Research Council), Stephen Brown(Screen), Elena Ziviani(University of Geneva), Alexander J. Whitworth(Medical Research Council)
Proceedings of the National Academy of Sciences
May 27, 2014
Cited by 127Open Access
Full Text

Abstract

Genetic analysis of Parkinson disease (PD) has identified several genes whose mutation causes inherited parkinsonism, as well as risk loci for sporadic PD. PTEN-induced kinase 1 (PINK1) and parkin, linked to autosomal recessive PD, act in a common genetic pathway regulating the autophagic degradation of mitochondria, termed mitophagy. We undertook a genome-wide RNAi screen as an unbiased approach to identify genes regulating the PINK1/Parkin pathway. We identified several genes that have a conserved function in promoting mitochondrial translocation of Parkin and subsequent mitophagy, most notably sterol regulatory element binding transcription factor 1 (SREBF1), F-box and WD40 domain protein 7 (FBXW7), and other components of the lipogenesis pathway. The relevance of mechanisms of autosomal recessive parkinsonism to sporadic PD has long been debated. However, with the recent identification of SREBF1 as a risk locus for sporadic PD, our findings suggest a common mechanistic link between autosomal recessive and sporadic PD, and underscore the importance of mitochondrial homeostasis.


Related Papers

No related papers found

Powered by citation graph analysis